UTAH MEDICAL PRODUCTS INC (UTMD) Stock Institutional Trading Activity


UTAH MEDICAL PRODUCTS INC (UTMD) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Sequoia Financial Advisors, and Bares Capital Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCSell-7,300193,614$10,834,639
Q3 2025Renaissance Technologies LLCSell-12,400200,914$12,651,555
Q2 2025Renaissance Technologies LLCSell-4,400213,314$12,141,833
Q1 2025Renaissance Technologies LLCSell-3,796217,714$12,200,693
Q4 2024Renaissance Technologies LLCSell-9,104221,510$13,616,220
Q3 2024Renaissance Technologies LLCBuy3,500230,614$15,430,383
Q2 2024Sequoia Financial AdvisorsBuy4,5974,597$307,126
Q2 2024Renaissance Technologies LLCSell-5,400227,114$15,173,486
Q1 2024Renaissance Technologies LLCBuy27,900232,514$16,534
Q4 2023Renaissance Technologies LLCSell-900204,614$17,233
Q3 2023Renaissance Technologies LLCBuy2,122205,514$17,674
Q2 2023Renaissance Technologies LLCSell-3,322203,392$18,956
Q1 2023Renaissance Technologies LLCSell-3,900206,714$19,590
Q4 2022Renaissance Technologies LLCSell-5,900210,614$21,173
Q3 2022Renaissance Technologies LLCSell-10,856216,514$18,471
Q2 2022Renaissance Technologies LLCBuy3,656227,370$19,531
Q1 2022Renaissance Technologies LLCBuy800223,714$20,103
Q4 2021Renaissance Technologies LLCSell-7,121222,914$22,291
Q3 2021Renaissance Technologies LLCSell-13,879230,035$21,356
Q2 2021Renaissance Technologies LLCSell-3,000243,914$20,742
Q1 2021Renaissance Technologies LLCSell-823246,914$21,383
Q4 2020Renaissance Technologies LLCBuy6,923247,737$20,884
Q3 2020Renaissance Technologies LLCBuy7,100240,814$19,234
Q2 2020Renaissance Technologies LLCBuy2,200233,714$20,712
Q1 2020Renaissance Technologies LLCSell-2,700231,514$21,774
Q4 2019Renaissance Technologies LLCSell-3,300234,214$25,272
Q3 2019Renaissance Technologies LLCSell-11,000237,514$22,763
Q2 2019Renaissance Technologies LLCBuy10,266248,514$23,783
Q1 2019Renaissance Technologies LLCSell-966238,248$21,025
Q4 2018Renaissance Technologies LLCSell-11,369239,214$19,874

Frequently asked questions about UTMD activity

  • Which institutional owners are buying UTMD?

    Institutional owners buying UTMD include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in UTMD activity?

    "Buy" means an investor increased their reported position in UTMD compared to the prior reporting period. This reflects growing exposure to UTAH MEDICAL PRODUCTS INC (UTMD) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in UTMD increasing?

    Institutional interest in UTMD can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.